Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
- 20 July 2020
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (31) , 18754-18763
Abstract
Significance: Neutralizing antibodies (NAbs) against HIV-1 are under clinical development. Despite demonstrated antiviral activity when used as treatment in HIV-infected people, the mechanism of action of NAbs remains controversial. Quantification of the relative contribution of Fab-mediated (neutralization of free virus) and Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC), phagocytosis, and complement fixation is essential to develop better therapies. Here, we treated chronically SHIV-infected rhesus macaques with a single dose of NAb VRC07-523LS with or without Fc modifications. Fc function contributes 21% to the antiviral activity of VRC07-523LS with an unmodified Fc region, when compared to NAb with Fc knockout mutations. However, NAbs with improved ADCC function in vitro did not show enhanced antiviral activity in vivo.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (HHSN261200800001E)
- U.S. Department of Energy (89233218CNA000001)
- HHS | National Institutes of Health (R01-AI028433)
- HHS | National Institutes of Health (R01-OD011095)
- HHS | National Institutes of Health (P01-AI131365)
- Bill and Melinda Gates Foundation (OPP1147555)
- HHS | National Institutes of Health (Intramural)
This publication has 41 references indexed in Scilit:
- A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in MacaquesJournal of Virology, 2012
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesJournal of Immunological Methods, 2011
- Enhanced antibody half-life improves in vivo activityNature Biotechnology, 2010
- Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virionsProceedings of the National Academy of Sciences, 2003
- A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In VivoJournal of Virology, 2003
- Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1Journal of Virology, 2001
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995